Systems pharmacology meets predictive, preventive, personalized and participatory medicine

Editorial

Sherry L Jenkins et al. Pharmacogenomics. 2013 Jan.

. 2013 Jan;14(2):119-22.

doi: 10.2217/pgs.12.186.

No abstract available

References

1. Hood L, Friend SH. Predictive, personalized, preventive, participatory (P4) cancer medicine. Nat Rev Clin Oncol. 2011;8(3):184–187. - PubMed
1. The 1000 Genomes Project Consortium. A map of human genome variation from population-scale sequencing. Nature. 2010;467(7319):1061–1073. - PMC - PubMed
1. Chen R, Mias GI, Li-Pook-Than J, et al. Personal omics profiling reveals dynamic molecular and medical phenotypes. Cell. 2012;148(6):1293–1307. - PMC - PubMed
1. Turnbaugh PJ, Ley RE, Hamady M, Fraser-Liggett CM, Knight R, Gordon JI. The human microbiome project. Nature. 2007;449(7164):804–810. - PMC - PubMed
1. Lamb J, Crawford ED, Peck D, et al. The connectivity map: using gene-expression signatures to connect small molecules, genes, and disease. Science. 2006;313(5795):1929–1935. - PubMed

1. The NIH Common Fund Office of Strategic Coordination. Library of Integrated Network-based Cellular Signatures (LINCS) www.commonfund.nih.gov/lincs.
1. US FDA. FDA Adverse Event Reporting System (FAERS) (formerly AERS) www.fda.gov/Drugs/GuidanceComplianceRegulatoryInformation/Surveillance/A....